3 Stocks I Saw on T...
Health Care: Drugs
Flamel Technologies (FLML: NASDAQ)
$4.43 0.09 | 1.98%
06/04/12 - 12:14 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 32.60M | 37.09M | 42.12M | 38.62M |
| Cost of Sales | 2.94M | 2.22M | 4.20M | 2.37M |
| Gross Operating Profit | 29.66M | 34.88M | 37.92M | 36.25M |
| Selling, General, and Administrative Expenses | 10.81M | 11.33M | 13.34M | 12.91M |
| Research & Development | 25.09M | 28.69M | 30.42M | 36.25M |
| Operating Income before D & A (EBITDA) | -6.24M | -5.14M | -5.84M | -12.91M |
| Depreciation & Amortization | 3.35M | 4.70M | 5.92M | 7.25M |
| Interest Income | 667.00K | 464.00K | 525.00K | 1.43M |
| Other Income - Net | 407.00K | 634.00K | -111.00K | 184.00K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -8.51M | -8.74M | -11.34M | -18.54M |
| Interest Expense | 73.00K | 24.00K | 100.00K | 18.00K |
| Pre-Tax Income | -8.58M | -8.77M | -11.44M | -18.56M |
| Income Taxes | 192.00K | 209.00K | 0.00 | -6.48M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -8.77M | -8.98M | -11.44M | -12.08M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -8.77M | -8.98M | -11.44M | -12.08M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -8.77M | -8.98M | -11.44M | -12.08M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-8.77M | -8.98M | -11.44M | -12.08M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -8.77M | -8.98M | -11.44M | -12.08M |
| Basic EPS from Continuing Ops. | -0.36 | -0.37 | -0.47 | -0.50 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.36 | -0.37 | -0.47 | -0.50 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.36 | -0.37 | -0.47 | -0.50 |
| Basic Normalized Net Income/Share | -0.36 | -0.37 | -0.47 | -0.50 |
| EPS fr Continuing Ops. | -0.36 | -0.37 | -0.47 | -0.50 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.36 | -0.37 | -0.47 | -0.50 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.36 | -0.37 | -0.47 | -0.50 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.36 | -0.37 | -0.47 | -0.50 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with FLML
- Portfolio NameUser Type
- Contributor10 Top-Rated Buys Under $10
- Contributor10 Stocks Under $10 With Up...
- Usergreentree
- UserSalvelinus Fontinalis
- UserBVF Inc.
- UserBoondoggler22 Portfolio 1
- UserFATZ 1
- Userndecas Portfolio 1
- UserRooster Fund
- UserLGS-1 Portfolio 1
Latest FLML Headlines from TheStreet
- Flamel Technologies' CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.07.12 | 11:05 am
- Flamel Technologies' CEO Discusses Q4 2011 Results - Earnings Call Transcript 03.15.12 | 01:03 pm
- Flamel Technologies's CEO Discusses Q3 2011 Results - Earnings Call Transcript 11.03.11 | 11:11 am
- Flamel Technologies CEO Discusses Q2 2011 Results - Earnings Call Transcript 07.26.11 | 01:07 pm
- Flamel Technologies CEO Discusses Q1 2011 Results - Earnings Call Transcript 05.09.11 | 10:05 am
- Flamel Technologies CEO Discusses Q4 2010 Results - Earnings Call Transcript 03.04.11 | 12:03 pm
- Flamel Technologies CEO Discusses Q3 2010 Results - Earnings Call Transcript 11.05.10 | 11:11 pm
- Flamel Technologies SA Q2 2010 Earnings Call Transcript 07.29.10 | 02:07 pm
- Thursday's Health Winners & Losers 12.20.07 | 02:12 pm
- Wednesday's Health Winners & Losers 12.05.07 | 04:12 am
Press Releases for FLML
- Flamel Technologies Announces First Quarter 2012 Results - Business Wire 05.07.12 | 07:05 am
- Flamel Technologies Announces Fourth Quarter And Year-End 2011 Results - Business Wire 03.14.12 | 06:03 pm
- Flamel Technologies Announces Acquisition Of Éclat Pharmaceuticals - Business Wire 03.14.12 | 06:03 pm
- Flamel Technologies Announces Profitable Third Quarter Results - Business Wire 11.02.11 | 04:11 pm
- Flamel Technologies Announces Multi-Year Supply Agreement With GlaxoSmithKline For Coreg CR™ Microparticles - Business Wire 10.18.11 | 08:10 am
- Eagle Pharmaceuticals And Flamel Technologies Announce Eagle To License Medusa Technology For Extended-Release Of Tigecycline - Business Wire 10.13.11 | 09:10 am
- Flamel Technologies And Digna Biotech Announce Multiple Product Development Agreement - Business Wire 06.27.11 | 08:06 am
- Flamel Technologies Announces Results Of Annual Meeting - Business Wire 06.24.11 | 08:06 am
- Flamel Technologies Announces Nomination Of Ambassador Craig Stapleton, Dr. Catherine Bréchignac And Mr. Guillaume Cerutti For Election To The Board Of Directors - Business Wire 05.31.11 | 08:05 am
- Flamel Technologies Announces Expanded Partnership Relations; First Quarter Results - Business Wire 05.09.11 | 06:05 am
Partner Headlines for FLML
- 16 Micro-Cap Stocks Being Targeted By Short Sellers - Seeking Alpha 10.26.11 | 09:10 am
- Investors roll positions on options expiration day - Reuters 08.20.10 | 03:08 pm
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.04.10 | 09:08 am
